Found 89 matching trials
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy
PHASE2The purpose of this study is to determine if bempedoic acid (ETC-1002) 180m...
Location
L-MARC Research Center
Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI
PHASE4AMUNDSEN-real is a phase IV, international (7 European countries), multicen...
Status
Active Not Recruiting
Location
ACTION Group, Institut de Cardiologie, Centre Hospitalier Universitaire Pitié Salpêtrière (APHP), UPMC
Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial
PHASE4This study (EPOCH-TECT) was a single-center, randomized, open-label, blinde...
Location
Affiliated Hospital of Xuzhou Medical University
Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan
N/AThe purpose of this post-marketing survey is to obtain real-world informati...
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2
PHASE3The primary objective was to evaluate the effect of 12 weeks of subcutaneou...
Effect of Evolocumab on Coronary Plaque Characteristics
PHASE4The aim of the study is to assess the effect of evolocumab on coronary plaq...
Location
Mount Sinai Hospital
Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Disease (FORWARD)
N/AThe primary objective was to evaluate the effect of treatment with evolocum...
Location
Beijing Anzhen Hospital, Capital Medical University
Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
PHASE3To evaluate the efficacy of subcutaneous (SC) evolocumab, compared to regul...
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
N/AEvaluation of adherence, persistence and efficacy of treatment with PCSK9 i...
Location
Ospedali dell'Ovest Vicentino
Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS
NAThe study is prospective, open-label, randomized, single-center study invol...
Location
Samara Regional Cardiology Dispansery